Nektar Therapeutics (NKTR)
35.78
-1.94
(-5.14%)
USD |
NASDAQ |
Oct 16, 16:00
35.76
-0.02
(-0.06%)
After-Hours: 20:00
Nektar Therapeutics Net Income (TTM) : -157.13M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -157.13M |
| March 31, 2026 | -158.10M |
| December 31, 2025 | -164.08M |
| September 30, 2025 | -120.74M |
| June 30, 2025 | -122.27M |
| March 31, 2025 | -133.04M |
| December 31, 2024 | -118.96M |
| September 30, 2024 | -168.30M |
| June 30, 2024 | -177.08M |
| March 31, 2024 | -175.84M |
| December 31, 2023 | -276.06M |
| September 30, 2023 | -293.66M |
| June 30, 2023 | -306.88M |
| March 31, 2023 | -414.82M |
| December 31, 2022 | -368.20M |
| September 30, 2022 | -454.16M |
| June 30, 2022 | -524.81M |
| March 31, 2022 | -491.26M |
| December 31, 2021 | -523.84M |
| September 30, 2021 | -495.40M |
| June 30, 2021 | -474.28M |
| March 31, 2021 | -428.76M |
| December 31, 2020 | -444.44M |
| September 30, 2020 | -439.40M |
| June 30, 2020 | -429.40M |
| Date | Value |
|---|---|
| March 31, 2020 | -459.69M |
| December 31, 2019 | -440.67M |
| September 30, 2019 | -426.72M |
| June 30, 2019 | -424.27M |
| March 31, 2019 | 657.47M |
| December 31, 2018 | 681.31M |
| September 30, 2018 | 745.70M |
| June 30, 2018 | 902.71M |
| March 31, 2018 | -128.62M |
| December 31, 2017 | -96.69M |
| September 30, 2017 | -105.06M |
| June 30, 2017 | -209.16M |
| March 31, 2017 | -197.89M |
| December 31, 2016 | -153.52M |
| September 30, 2016 | -165.46M |
| June 30, 2016 | -130.44M |
| March 31, 2016 | -134.50M |
| December 31, 2015 | -81.18M |
| September 30, 2015 | -72.72M |
| June 30, 2015 | 6.085M |
| March 31, 2015 | 26.10M |
| December 31, 2014 | -53.92M |
| September 30, 2014 | -55.89M |
| June 30, 2014 | -143.04M |
| March 31, 2014 | -153.15M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Eli Lilly & Co. | 26.71B |
| Inovio Pharmaceuticals, Inc. | -67.43M |
| Tonix Pharmaceuticals Holding Corp. | -159.67M |
| Capricor Therapeutics, Inc. | -129.42M |
| Kyntra Bio, Inc. | -30.91M |